Glimepiride 4 mg Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of glimepiride 4 mg
tablets (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by TEVA
Pharmaceuticals USA) with that of AMARYL® tablets (Aventis) in healthy, adult, non-smoking
subjects under non-fasting conditions.